The Latin America, Middle East and Africa AI In Cancer Diagnostics Market would witness market growth of 32.5% CAGR during the forecast period (2022-2028).
In the detection of cancer, the Imaging process is used for developing precise photos of the body's organs and structure. The imaging is also used to identify the abnormalities, condition, and location of the tumor. It can be utilized in various procedures such as biopsies and surgeries. Reflecting imaging, emission imaging, and transmission imaging are the three various types of imaging utilized in diagnosing cancer. X-rays, CT scans, and fluoroscopy images are sent from radiological exams.
Additionally, many other researchers can quickly determine the subtype of cancer by uploading methylation profiles into research which also delivers a confidence level that indicates the probability that the result is precise. As per the German neuropathologist, Andreas von Deimling, moreover about 1000 such reports are submitted each year.
As the United Arab Emirates (UAE) is becoming one of the fastest-growing economies the number of patients related to chronic diseases like cancer is also increasing. Even after the initial detection efforts and screening the number of registered cases and fatalities in UAE has increased significantly, this can be attributed to the fact that the coverage of people is less than the targeted population.
The Brazil market dominated the LAMEA AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $8.5 million by 2028. The Argentina market is showcasing a CAGR of 33.2% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 32.1% during (2022 - 2028).
Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global AI In Cancer Diagnostics Market is Predict to reach $509 Million by 2028, at a CAGR of 28.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
By End-user
By Component
By Cancer Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
